http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101885678-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df948cc654d8bc531c7293a732309424
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0626
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0618
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0613
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
filingDate 2018-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d07cb0c59221bb7e485ef5946216faef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21f69c945cb5acbada116f38fdb28908
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f24421e3f5a0355a886c3e55ed19041
publicationDate 2018-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101885678-B1
titleOfInvention Light irradiation device for inhibiting the accumulation of amyloid beta plaque
abstract The present invention relates to a light irradiation control device for suppressing the accumulation of beta amyloid plaques, and more particularly, it relates to an apparatus and a method for controlling the irradiation of beta-amyloid plaques by using visible light energy to form epidermis layers or dermis, The nerve endings distributed in the layer are stimulated for a certain period of time and the nerve endings are connected to the nervous system and the nitrergic nerve terminals are connected to the nerve endings such as nitric oxide And secretion of the amyloid beta plaque by inducing cerebral blood circulation or lymphatic circulation enhancement by relaxation of the cerebral blood vessel or lymph vessel which is in contact with the nitrergic nerve terminals by the secreted substance, To control the irradiation of light. By using the present invention, visible light irradiation repeated for several months (for example, 3 to 6 months) is performed on the skin area of the specific region of the neck and the back of the human body for a fixed time every day, It is possible to induce repetitive blood circulation or lymphatic circulation enhancement and to improve oxygenation and nutrition in damaged cells that function as a brain clearance system due to enhancement of blood circulation or lymphatic circulation in the brain, Can be prevented or treated by slowly recovering the function of the amyloid plaque and releasing the amyloid beta plaque.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200145814-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019164110-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102535706-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3673954-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111375138-A
priorityDate 2018-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004321249-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120131316-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120128322-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130134022-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID190367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID945
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID190367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559537

Total number of triples: 34.